Back to Search
EDWARD JEFFES, M.D.
M.D.
Dermatology Physician
NPI: 1154438554Individual
Specialties, Licenses & Credentials
MOHS-Micrographic Surgery Physician
Dermatology — MOHS-Micrographic Surgery
Code: 207ND0101X
G49308(CA)
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
G49308(CA)
Research & Publications (16)
Antiangiogenic drugs synergize with a membrane macrophage colony-stimulating factor-based tumor vaccine to therapeutically treat rats with an established malignant intracranial glioma.
PMID 15728459·J Immunol·2005
7-preclinical
Levulan: the first approved topical photosensitizer for the treatment of actinic keratosis.
PMID 12060513·J Dermatolog Treat·2002
6-review
Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light.
PMID 11423841·J Am Acad Dermatol·2001
3-trial
Etanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infection.
PMID 19663835·Clin Exp Dermatol·2010
5-case
Macrophage colony stimulating factor: not just for macrophages anymore! A gateway into complex biologies.
PMID 18687298·Int Immunopharmacol·2008
6-review
Unraveling the paradoxes of HIV-associated psoriasis: a review of T-cell subsets and cytokine profiles.
PMID 17498423·Dermatol Online J·2007
6-review
Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials.
PMID 14732659·Arch Dermatol·2004
3-trial
A case of familial cold autoinflammatory syndrome confirmed by the presence of a CIAS1 mutation.
PMID 15149524·Br J Dermatol·2004
5-case
Intra-arterial administration of TNF-alpha followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinoma.
PMID 12536235·Cancer Immunol Immunother·2003
7-preclinical
Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a "paraptosis"-induced pathway that promotes systemic immunity against intracranial T9 gliomas.
PMID 12149220·Blood·2002
7-preclinical
T9 glioma cells expressing membrane-macrophage colony stimulating factor produce CD4+ T cell-associated protective immunity against T9 intracranial gliomas and systemic immunity against different syngeneic gliomas.
PMID 12142031·Cell Immunol·2002
7-preclinical
Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8+ T-cell immunity against the parental tumor.
PMID 11708879·Mol Ther·2001
7-preclinical
Dexamethasone increases the expression of membrane macrophage colony stimulating factor from retrovirally transduced tumor cells expressing macrophage colony stimulating factor.
PMID 11357885·Int Immunopharmacol·2001
7-preclinical
Membrane macrophage colony-stimulating factor on MADB106 breast cancer cells does not activate cytotoxic macrophages but immunizes rats against breast cancer.
PMID 11237678·Mol Ther·2001
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 26081 MERIT CIRCLE #109
LAGUNA HILLS, CA 92653 - Phone
- (949) 582-7699
Quick Facts
- NPI
- 1154438554
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 16
Are you this provider?
Claim Your Profile